X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
aged (11) 11
female (11) 11
humans (11) 11
male (11) 11
cardiac & cardiovascular systems (9) 9
middle aged (9) 9
cardiovascular (8) 8
abridged index medicus (7) 7
clopidogrel (6) 6
aspirin (5) 5
heart failure (5) 5
mortality (5) 5
nesiritide (5) 5
outcomes (5) 5
treatment outcome (5) 5
acute disease (4) 4
cardiovascular disease (4) 4
cardiovascular diseases (4) 4
care and treatment (4) 4
diagnosis (4) 4
double-blind method (4) 4
heart attacks (4) 4
hospitalization (4) 4
ischemia (4) 4
patients (4) 4
peripheral arterial disease - drug therapy (4) 4
peripheral artery disease (4) 4
stroke (4) 4
ticagrelor (4) 4
adenosine - analogs & derivatives (3) 3
bleeding (3) 3
cardiovascular events (3) 3
cerebral infarction (3) 3
clinical medicine (3) 3
clinical outcomes (3) 3
clinical trials (3) 3
confidence intervals (3) 3
diabetes (3) 3
family medical history (3) 3
heart failure - drug therapy (3) 3
heart failure - physiopathology (3) 3
myocardial infarction (3) 3
natriuretic agents - therapeutic use (3) 3
natriuretic peptide, brain - therapeutic use (3) 3
platelet aggregation inhibitors - adverse effects (3) 3
platelet aggregation inhibitors - therapeutic use (3) 3
prevention (3) 3
prognosis (3) 3
purinergic p2y receptor antagonists - therapeutic use (3) 3
risk stratification (3) 3
ticlopidine - analogs & derivatives (3) 3
trial (3) 3
vascular diseases (3) 3
acute heart failure (2) 2
acute myocardial-infarction (2) 2
adenosine - administration & dosage (2) 2
adenosine - adverse effects (2) 2
adenosine - therapeutic use (2) 2
analysis (2) 2
ankle (2) 2
anticoagulants (2) 2
antithrombotic (2) 2
arteriosclerosis (2) 2
atherosclerosis (2) 2
cardiac and cardiovascular systems (2) 2
cardiovascular system & cardiology (2) 2
cause of death - trends (2) 2
drug therapy (2) 2
dyspnea - physiopathology (2) 2
edema (2) 2
health risks (2) 2
heart failure - mortality (2) 2
hemorrhage - chemically induced (2) 2
human health and pathology (2) 2
infarction (2) 2
kardiologi (2) 2
klinisk medicin (2) 2
life sciences (2) 2
limb amputation (2) 2
management (2) 2
medical and health sciences (2) 2
medicin och hälsovetenskap (2) 2
medicine, general & internal (2) 2
myocardial infarction - etiology (2) 2
natriuretic agents - administration & dosage (2) 2
natriuretic peptide (2) 2
natriuretic peptide, brain - administration & dosage (2) 2
odds ratio (2) 2
outcome assessment (2) 2
patient outcomes (2) 2
peripheral arterial disease - complications (2) 2
peripheral arterial disease - diagnosis (2) 2
peripheral vascular disease (2) 2
peripheral vascular diseases (2) 2
risk (2) 2
risk assessment - methods (2) 2
stroke - etiology (2) 2
surgery (2) 2
survival rate - trends (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2017, Volume 376, Issue 1, pp. 32 - 40
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 175, pp. 86 - 93
Abstract Background Despite overwhelming data demonstrating the efficacy of antiplatelet therapy in heart disease and stroke, data in peripheral artery disease... 
Cardiovascular | AZD6140 | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | ANTAGONIST | CARDIOVASCULAR EVENTS | ANKLE-BRACHIAL INDEX | PREVENTION | PREVALENCE | HEALTH | ACUTE CORONARY SYNDROME | ASPIRIN | Stroke - prevention & control | Ankle Brachial Index | Humans | Middle Aged | Peripheral Arterial Disease - drug therapy | Male | Treatment Outcome | Adenosine - administration & dosage | Peripheral Arterial Disease - complications | Disease Progression | Ticlopidine - analogs & derivatives | Stroke - etiology | Peripheral Arterial Disease - diagnosis | Adenosine - adverse effects | Adenosine - analogs & derivatives | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Aged | Myocardial Infarction - prevention & control | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Care and treatment | Coronary heart disease | Cardiac patients | Analysis | Disease prevention | Aspirin | Stroke | Heart attacks | Blood platelets | Mortality | Diabetes | Family medical history | Drug therapy | Acute coronary syndromes | Cardiology | Drug dosages | cardiovascular events | risk-factors | Klinisk medicin | heart-association | antagonist | acute coronary syndromes | Clinical Medicine | task-force | prevalence | Cardiovascular System & Cardiology | aspirin | ankle-brachial index | prevention
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 170, Issue 2, pp. 290 - 297.e1
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2019, Volume 380, Issue 16, pp. 1509 - 1524
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 06/2016, Volume 117, Issue 11, pp. 1771 - 1778
Journal Article
Journal Article
Vascular Medicine, ISSN 1358-863X, 12/2018, Volume 23, Issue 6, pp. 523 - 530
Patients with peripheral artery disease (PAD) are at heightened risk of cardiovascular morbidity and mortality. We sought to evaluate the risk of concomitant... 
cardiovascular events | coronary artery disease | major bleeding | peripheral artery disease (PAD) | ticagrelor | antiplatelet therapy | acute limb ischemia | MISSED OPPORTUNITIES | EVENTS | ATHEROSCLEROSIS | UNDERUSE | ASPIRIN | IMPROVEMENT | PERIPHERAL VASCULAR DISEASE | Prospective Studies | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Male | Peripheral Arterial Disease - complications | Fibrinolytic Agents - adverse effects | Percutaneous Coronary Intervention - instrumentation | Ticagrelor - adverse effects | Coronary Artery Bypass - mortality | Time Factors | Fibrinolytic Agents - therapeutic use | Female | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Stents | Ticagrelor - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Risk Factors | Peripheral Arterial Disease - drug therapy | Treatment Outcome | Coronary Artery Disease - mortality | Coronary Artery Bypass - adverse effects | Stroke - etiology | Coronary Artery Disease - therapy | Peripheral Arterial Disease - diagnosis | Coronary Artery Disease - diagnosis | Coronary Artery Disease - complications | Aged | Clopidogrel - adverse effects | Clopidogrel - therapeutic use | Percutaneous Coronary Intervention - adverse effects | Myocardial infarction | Cerebral infarction | Surgical implants | Stroke | Statistical analysis | Coronary artery | Health risks | Risk | Cardiovascular disease | Coronary artery disease | Patients | Bleeding | Morbidity | Vascular diseases | Ischemia | Coronary vessels | Surgery | Implants | Clopidogrel | Infarction | Cardiovascular diseases | Heart diseases | Significance
Journal Article
Circulation, ISSN 0009-7322, 01/2017, Volume 135, Issue 3, pp. 241 - 250
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 11, pp. A2087 - A2087
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 10, pp. E620 - E620
  Stepwise logistic regression was used to identify baseline factors related to hypotension, and a Cox proportional hazards model was used to examine the... 
Cardiovascular | Internal Medicine | Heart failure | Confidence intervals | Hospitalization | Mortality
Journal Article